Skip to main content
. Author manuscript; available in PMC: 2011 May 16.
Published in final edited form as: J Am Coll Cardiol. 2008 Apr 15;51(15):1490–1497. doi: 10.1016/j.jacc.2008.01.015

Table 1.

Echocardiography: Effects of Increased ACVI Expression

AC-Off (n = 15) AC-On (n = 19)


Before Rx 5 Weeks After Rx Change Before Rx 5 Weeks After Rx Change p Value
HR (beats/min) 394 ± 14 412 ± 15 18 ± 13 408 ± 11 430 ± 12 21 ± 17 0.88
EDD (mm) 5.5 ± 0.1 5.6 ± 0.1 0.1 ± 0.1 5.9 ± 0.2 5.9 ± 0.2 0.03 ± 0.1 0.70
ESD (mm) 4.8 ± 0.1 5.0 ± 0.2 0.2 ± 0.1 5.1 ± 0.2 5.0 ± 0.3 0.1 ± 0.1 0.17
PWd (mm) 0.66 ± 0.03 0.57 ± 0.02 0.09 ± 0.03 0.64 ± 0.02 0.61 ± 0.02 0.03 ± 0.02 0.14
IVSd (mm) 0.48 ± 0.02 0.47 ± 0.02 0.01 ± 0.02 0.49 ± 0.03 0.48 ± 0.02 0.02 ± 0.02 0.89
FAC (%) 13 ± 1 12 ± 1 1 ± 1 13 ± 1 16 ± 1 3 ± 1 0.0001
LVEF (%) 24 ± 1 22 ± 1 2 ± 1 24 ± 2 28 ± 2 5 ± 1 0.0001

Values represent mean ± SE. The p values are from the Student t test comparing changes in each parameter between groups (2-tailed, unpaired).

ACVI = adenylyl cyclase VI; EDD = end-diastolic diameter; ESD = end-systolic diameter; FAC = fractional area change; HR = heart rate; IVSd = interventricular septal diastolic wall thickness; LVEF = left ventricular ejection fraction; PWd = posterior diastolic wall thickness; Rx = treatment.